Mazumdar-Shaw’s bold biotech mission: Affordable, accessible healthcare
About this episode
Kiran Mazumdar-Shaw discusses her journey in building a successful biotech company in Asia amidst various challenges.
Biotech entrepreneurs across Asia are navigating funding gaps, weak innovation ecosystems, and unpredictable regulatory systems. For many, these challenges make it difficult to scale science-led businesses and deliver affordable healthcare solutions. In this episode, host Gautam Kumra, Chairman of McKinsey Asia, sits down with Kiran Mazumdar-Shaw, Founder & Chairperson, Biocon Group. They discuss how she overcame a lack of funding, limited infrastructure, and regulatory hurdles to build one of Asia’s first and most successful biotech companies — pioneering affordable biosimilars, shaping biotech policy in India, and scaling purpose-driven innovation from the ground up. The episode also features McKinsey partner Cheryl SH Lim, and Director of Learning, CEO Institute, Jennifer Chiang. See www.mckinsey.com/privacy-policy for privacy information
Topics covered
- biotech
- healthcare
- innovation
- regulatory systems
Keywords
- biotech policy
- innovation ecosystems
- affordable healthcare
- biosimilars
More episodes of McKinsey Future of Asia
- How foreign direct investment is shaping future business
- Leading a metabolic health revolution in Asia
- Respect above all: Narayana Murthy’s core business belief
- Exploring the frontier: Technology trends in Asia
- Propelling Indonesia's productivity: Reaching high income by 2045
- Trade, tech, and geopolitics in Asia in 2025: A post-Davos discussion
Explore listener stats, chart rankings, contacts and more on the McKinsey Future of Asia podcast page.